Favipiravir CAS 259793-96-9 T-705 Maʻemaʻe ≥99.0% (HPLC) COVID-19 API Hale Kūlana Kiʻekiʻe
Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Hāʻawi Kalepa Favipiravir a me nā mea pili e pili ana:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Inoa Kimia | ʻO Favipiravir |
Nā huaʻōlelo like | T-705;6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide |
Helu CAS | 259793-96-9 |
Helu CAT | RF-API18 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram |
ʻĀpana Molekala | C5H4FN3O2 |
Kaumaha Molecular | 157.1 |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Keʻokeʻo a hiki i ka pauda keʻokeʻo |
ʻIkepili 1H-NMR | Kūlike me ka hoʻolālā i manaʻo ʻia |
ʻIke HPLC | ʻO ka manawa paʻa o ka piko nui ma ka hoʻomākaukau laʻana pono e kūlike me ka manawa paʻa o ka piko nui i ka hoʻomākaukau maʻamau kuhikuhi |
Identification Mass | Kūlike ʻo Mass Spectrum me ka hoʻolālā i manaʻo ʻia |
Lae hehee | 188.0 ℃-193.0 ℃ |
Na mea pili (Hoʻoponopono ʻĀpana) | ʻO kēlā me kēia haumia hoʻokahi: ≤0.10% (HPLC) |
Huina haumia: ≤1.0% (HPLC) | |
Maʻemaʻe / Kaʻina Hanana | ≥99.0% (HPLC) |
Māmā (KF) | ≤0.50% |
Koena ma ka Ignition | ≤0.10% |
Nā Metala Kaumaha | ≤20ppm |
Koena Solvents | |
Methanol | ≤3000ppm |
Isopropanol | ≤5000ppm |
n-Heptana | ≤5000ppm |
Ethanol | ≤5000ppm |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Mea Hana Lapaʻau Hoʻoikaika (API);Lapaʻau ʻana o COVID-19 |
Pūʻolo: ʻO ka ʻōmole, ʻeke Aluminum foil, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
ʻO Favipiravir (T-705) (CAS 259793-96-9) kekahi o nā pūhui 5 i ʻōlelo ʻia e WHO no ka hoʻokolokolo ʻana i ka mālama ʻana i ka COVID-19.ʻO Favipiravir kahi mea pale koho o ka RNA polymerase hilinaʻi RNA me ka hana e kūʻē i nā maʻi RNA he nui, nā maʻi influenza, West Nile virus, ka maʻi maʻi melemele, ka maʻi maʻi wāwae-a-waha a me nā flaviviruses ʻē aʻe, arenaviruses, bunyaviruses a me alphaviruses.ʻO Favipiravir kahi lāʻau lapaʻau antiviral ākea ākea i hoʻomaʻemaʻe ʻia e ka Drugs Controller General of India (DCGI) i ka pule i hala no ka hoʻohana ʻana i ka "hoʻopaʻa ʻia" ma waena o nā maʻi maʻi Covid-19.Ua hoʻokumu mua ʻia ʻo Favipiravir i ka hopena o 1990s e kahi hui i kūʻai ʻia ma hope e ka ʻoihana Iapana ʻo Fujifilm ma ke ʻano o kāna hoʻololi ʻana mai ka ʻoihana kiʻi i ka mālama olakino.Ma hope o ka hoʻāʻo ʻia ʻana e kūʻē i ka nui o nā maʻi maʻi, ua ʻae ʻia ka lāʻau lapaʻau ma Iapana i ka makahiki 2014 no ka hoʻohana pilikia ʻana i nā maʻi maʻi maʻi a i ʻole e mālama i nā maʻi maʻi hou.